Clinical Trial Update: Treatment of Sunflower Syndrome With ZX008 (Fenfluramine Hydrochloride) in Children and Young Adults (Ages 4-25). [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating ZX008 (fenfluramine hydrochloride) for Sunflower Syndrome/Photosensitive Epilepsy in children and young adults (ages 4-25) has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Photosensitive Epilepsy
• Sunflower Syndrome

Drugs mentioned

• ZX008 (fenfluramine hydrochloride) (fenfluramine hydrochloride)

Snippet

Sponsor: Elizabeth Anne Thiele | Conditions: Photosensitive Epilepsy | Phase 3 | Status: COMPLETED | Results posted: 2023-02-08